User Benefits
Application
News
A Biological Model of the Ageing Metabolome Reveals
Potential Clinically Relevant Biomarkers
Emily Armitage
1
, Domenica Berardi
2
, Alan Barnes
1
, Neil Loftus
1
, Gillian Farrell
2
, Abdullah Al
Sultan
2
, Ashley McCulloch
2
, Zahra Rattray
1
, Nicholas JW Rattray
1
1 Shimadzu Corporation, Manchester, UK
2 Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, UK
High Performance Liquid Chromatograph Mass Spectrometer
Applying an LC/QTOF method with HILIC separation to an untargeted metabolomics workflow to identify metabolic profiles in
biological cell extracts and cell culture media samples.
A flexible workflow for untargeted metabolomics analysis generates data compatible for analysis using LabSolutions Insight Explore as
well as highly cited third-party software solutions for metabolomics such as MS-DIAL and MetaboAnalyst.
DIA-MS/MS analysis enables library searching of all detected metabolites in all samples in an untargeted approach.
Introduction
Ageing can have a profound effect on the metabolome through
mechanisms including mitochondrial dysfunction, genomic
instability, altered intercellular communication and cellular
senescence. In this research, serially passaged human foreskin
fibroblasts (HFF-1 cells) and their media have been considered
as a biological model to increase our understanding of the
ageing metabolome. Untargeted metabolomic analysis of cell
and media extracts has revealed potential clinically relevant
biomarkers of ageing.
An end-to-end workflow for untargeted metabolomics analysis
is presented based on an untargeted HILIC-DIA-MS/MS method
for data acquisition, MS-DIAL and MetaboAnalyst for data
analysis and LabSolutions Insight Explore for metabolite
identification. Fig. 1 highlights extracted ion chromatograms for
polar metabolites in a cell extract analysed using this analytical
method.
Table 1 Analytical conditions
Sample analysis
A biological model of cell senescence considered the
comparison of HFF-1 cells and media from an early passage
versus a later passage representative of a senescent state.
Extracts from HFF-1 cells and culture media at passage 3 and
passage 20 were analysed with a high-resolution untargeted
metabolomics LC/QTOF method (LCMS-9030 Q-TOF). The
analysis was performed using the analytical conditions
described in Table 1. Samples were analysed separately for cells
and media. Each batch was analysed in a randomised order.
UHPLC: Nexera X2
Column Shim-pack Velox HILIC (2.1x100 mm, 2.7 µm,
PN: 227-32025-03); column maintained at
40 ˚C
Flow Rate 0.3 mL/min (0-13 min); 0.4 mL/min (13-17
min); 0.3 mL/min (17-18 min)
Mobile Phase A: Water + 10 mM ammonium formate +
0.1% formic acid
B: Acetonitrile:water [92:8] + 10 mM
ammonium formate + 0.1% formic acid
Rinse (R0/R1/R2) IPA/MeOH/MeCN/H
2
O (1:1:1:1) + 1% formic
acid
Gradient 98% B (0-1.5 min); 65% B (11 min); 10% B
(12.5-14 min); 98% B (14.25-18 min)
Injection 0.5 µL; autosampler temperature 4 ˚C
Mass Spectrometer: LCMS-9030
Interface 300 ˚C, 1.5 kV (ESI+) / -3.0 kV (ESI-)
Heat block, DL 400 ˚C, 250 ˚C
Gas flow rates Nebulizing gas 3 L/min;
Heating gas 10 L/min;
Drying gas 15 L/min
CID gas pressure 230 kPa
MS TOF-MS (m/z 60-1000)
MS/MS 27 DIA-MS/MS (m/z 40-1000;
precursor isolation 35 Da; collision energy
spread 5-55 V
Total cycle time
(MS and MS/MS)
0.991 seconds
RT (min)
1 2 3 4 5 6 7 8 9 10 11 12
Polar metabolites and lipids
Amino-acids, nucleotides, nucleosides,
vitamins, carnitines, lyso-phospholipids
Fig. 1 Mass chromatograms for a panel of polar metabolites in a cell
extract separated using a HILIC phase (precursor ion ±5 ppm).